Captagon, the trademark name for the synthetic stimulant Fenethylline, has been a subject of intrigue and controversy since its inception in 1961. Originally intended for the treatment of hyperactivity, depression, and narcolepsy, Captagon quickly gained notoriety due to its addictive and hallucinogenic properties. This article delves into the history, pharmacology, and societal impact of Captagon, … Leggi tutto Captagon: Unraveling the complexities of a controversial stimulant used by terrorists and “Pharmaceutical Soldier” – Performance Enhancing Drugs on the Battlefield